Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$52.51 - $80.91 $13.7 Million - $21 Million
-259,982 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$52.2 - $75.23 $13.5 Million - $19.5 Million
-258,840 Reduced 49.89%
259,982 $14.2 Million
Q1 2021

May 14, 2021

SELL
$62.84 - $87.68 $58.3 Million - $81.4 Million
-928,032 Reduced 64.14%
518,822 $38.3 Million
Q3 2020

Nov 13, 2020

BUY
$29.36 - $47.1 $42.5 Million - $68.1 Million
1,446,854 New
1,446,854 $54.6 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $68.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.